Getting In Cheap On Sino Biopharmaceutical Limited (HKG:1177) Might Be Difficult
Jan 13
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies39
- 7D1.7%
- 3M-17.1%
- 1Y3.9%
- YTD-3.8%
The Pharma industry is up 1.7% in the last week, with Hansoh Pharmaceutical Group up 3.5%. During this same period, the China Traditional Chinese Medicine Holdings underperformed, falling 8.3%. This means that the industry has gained 3.9% over the past year. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 22 Jan 2025 | HK$403.8b | HK$460.1b | HK$31.7b | 8x | 12.7x | 0.9x |
| Fri, 20 Dec 2024 | HK$434.4b | HK$460.4b | HK$31.8b | 8.4x | 13.7x | 0.9x |
| Sun, 17 Nov 2024 | HK$432.9b | HK$463.7b | HK$31.5b | 8.2x | 13.8x | 0.9x |
| Tue, 15 Oct 2024 | HK$512.8b | HK$474.4b | HK$32.9b | 7.9x | 15.6x | 1.1x |
| Thu, 12 Sep 2024 | HK$423.5b | HK$473.1b | HK$32.8b | 7.3x | 12.9x | 0.9x |
| Sat, 10 Aug 2024 | HK$440.9b | HK$463.2b | HK$32.8b | 7.4x | 13.4x | 1x |
| Mon, 08 Jul 2024 | HK$445.9b | HK$461.5b | HK$33.7b | 7.9x | 13.2x | 1x |
| Wed, 05 Jun 2024 | HK$470.7b | HK$464.3b | HK$33.9b | 8.3x | 13.9x | 1x |
| Fri, 03 May 2024 | HK$473.1b | HK$463.3b | HK$33.7b | 7.5x | 14x | 1x |
| Sun, 31 Mar 2024 | HK$445.8b | HK$465.7b | HK$36.5b | 7.7x | 12.2x | 1x |
| Tue, 27 Feb 2024 | HK$444.5b | HK$470.7b | HK$33.5b | 7.7x | 13.3x | 0.9x |
| Thu, 25 Jan 2024 | HK$418.3b | HK$474.2b | HK$34.0b | 6.9x | 12.3x | 0.9x |
| Sat, 23 Dec 2023 | HK$463.7b | HK$473.0b | HK$33.9b | 7.5x | 13.7x | 1x |
| Mon, 20 Nov 2023 | HK$502.3b | HK$470.8b | HK$32.1b | 7x | 15.6x | 1.1x |
| Wed, 18 Oct 2023 | HK$442.5b | HK$469.3b | HK$31.5b | 7.2x | 14x | 0.9x |
| Fri, 15 Sep 2023 | HK$424.5b | HK$470.0b | HK$31.6b | 6.7x | 13.4x | 0.9x |
| Sun, 13 Aug 2023 | HK$439.9b | HK$446.6b | HK$28.2b | 8.6x | 15.6x | 1x |
| Tue, 11 Jul 2023 | HK$479.7b | HK$445.5b | HK$27.8b | 9.4x | 17.3x | 1.1x |
| Thu, 08 Jun 2023 | HK$511.2b | HK$448.6b | HK$27.9b | 8.4x | 18.3x | 1.1x |
| Sat, 06 May 2023 | HK$571.5b | HK$453.4b | HK$28.5b | 9.2x | 20.1x | 1.3x |
| Mon, 03 Apr 2023 | HK$539.3b | HK$453.2b | HK$28.9b | 9.4x | 18.7x | 1.2x |
| Wed, 01 Mar 2023 | HK$585.7b | HK$443.9b | HK$35.0b | 11.7x | 16.7x | 1.3x |
| Fri, 27 Jan 2023 | HK$642.9b | HK$447.3b | HK$35.6b | 10.9x | 18.1x | 1.4x |
| Sun, 25 Dec 2022 | HK$585.2b | HK$441.7b | HK$34.7b | 10.6x | 16.9x | 1.3x |
| Tue, 22 Nov 2022 | HK$609.7b | HK$437.7b | HK$34.0b | 9.7x | 17.9x | 1.4x |
| Thu, 20 Oct 2022 | HK$557.9b | HK$513.1b | HK$38.9b | 8.6x | 14.3x | 1.1x |
| Sat, 17 Sep 2022 | HK$528.7b | HK$518.5b | HK$40.6b | 9.2x | 13x | 1x |
| Mon, 15 Aug 2022 | HK$587.7b | HK$513.4b | HK$51.4b | 8x | 11.4x | 1.1x |
| Wed, 13 Jul 2022 | HK$635.4b | HK$514.0b | HK$52.1b | 8.7x | 12.2x | 1.2x |
| Fri, 10 Jun 2022 | HK$584.9b | HK$515.1b | HK$52.0b | 9.2x | 11.2x | 1.1x |
| Sun, 08 May 2022 | HK$553.5b | HK$514.3b | HK$51.4b | 8.1x | 10.8x | 1.1x |
| Tue, 05 Apr 2022 | HK$653.8b | HK$525.3b | HK$53.0b | 9x | 12.3x | 1.2x |
| Thu, 03 Mar 2022 | HK$648.9b | HK$501.4b | HK$45.3b | 9.5x | 14.3x | 1.3x |
| Sat, 29 Jan 2022 | HK$653.3b | HK$496.8b | HK$43.8b | 9x | 14.9x | 1.3x |
Price to Earnings Ratio
14.9x
Current Industry PE
- Investors are pessimistic on the Hong Kong Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 12.7x which is lower than its 3-year average PE of 14.5x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.88x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 10% per year over the last three years,
- Revenues have also declined 2.6% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 3.38% | |
| Healthcare | 2.49% | |
| Pharma | 1.72% | |
| Pharma | 1.72% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$17.22 | 3.5% +HK$3.4b | 43.3% | PE20.3x | |
| 3933 United Laboratories International Holdings | HK$11.62 | 4.9% +HK$981.2m | 69.9% | PE6.8x | |
| 1093 CSPC Pharmaceutical Group | HK$4.45 | 1.8% +HK$920.2m | -22.9% | PE9.3x | |
| 1177 Sino Biopharmaceutical | HK$2.91 | 1.0% +HK$535.4m | -2.3% | PE23.1x | |
| 867 China Medical System Holdings | HK$7.24 | 2.0% +HK$338.3m | -38.9% | PE11.8x |
